Geron ends brain cancer drug study, cuts 43 jobs

Geron Corp. shares tumbled 21 percent in after-hours trading Monday after the company said that it will end development of an experimental cancer drug and eliminating 43 jobs.

http://www.biosciencetechnology.com/News/FeedsAP/2012/12/geron-ends-brain-cancer-drug-study-cuts-43-jobs/